Aandeel KREBSBIO KREBS BIOCHEMICALS & INDUSTRIES LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Krebs Biochemicals & Industries Limited

Aandelen

KREBSBIO

INE268B01013

Beurs gesloten - Bombay S.E.
Andere beurzen
 12:00:48 10-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
65,89 INR -4,55% Intraday-grafiek van Krebs Biochemicals & Industries Limited -9,22% -15,89%
15/04 Krebs Biochemicals & Industries Limited kondigt ontslag aan van Keyur Doshi als Secretaris van de vennootschap, Compliance Officer CI
12/02 Krebs Biochemicals & Industries Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023
Krebs Biochemicals Trims Net Loss in Fiscal Q4
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Krebs Biochemicals Names New CFO
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer
Krebs Biochemicals & Industries Limited Approves CFO Changes
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022
Krebs Biochemicals & Industries : Financial Result Updates
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers KREBSBIO
  4. Nieuws Krebs Biochemicals & Industries Limited
  5. Andere talen